Head-to-head · Value Score
CoreAge Rx vs Eden
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Eden a 81. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameEden
#60 · Grade B · Good Value
Est. first month
$239/mo
Save ~82% vs brand-nameFDA warning letter. The FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026. Check it on the FDA database.
Get this deal Full Eden review →The verdict
CoreAge Rx takes it on Value Score, 93 to 81 — an est. $99/mo first month, with no teaser step-up baked in. Eden isn't out of it: Shoppers who'll trade a lower price for maximum disclosure and rock-solid nationwide access.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Eden |
|---|---|---|
| Value Score | 93 (A+) | 81 (B) |
| Est. first month | $99/mo | $239/mo |
| Save vs brand-name | ~89% | ~82% |
| Semaglutide | $99/mo | $239/mo |
| Tirzepatide | $149/mo | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Eden
The priciest of the top programs we track, but the most transparent — you pay up, never get baited.
Why it's a deal
- Highest transparency — clear supply-chain and clinician disclosure
- Available in all 50 states
- Both molecules offered, no teaser tier
The fine print
- Most expensive on semaglutide among the top programs ($239/mo)
- Compounded only — no brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Eden.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.